Key terms
About ATAI
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ATAI news
Yesterday
11:35am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Apr 17
7:05am ET
Atai Life announces publication of Beckley Psytech’s Phase 1 study of BPL-003
Apr 11
10:24am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Apr 04
11:06am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Apr 03
9:24am ET
Maxim upgrades Atai to Buy amid renewed psychedelic interest
Apr 03
7:48am ET
Atai Life Sciences upgraded to Buy from Hold at Maxim
Apr 03
6:59am ET
Atai Life Sciences undervalued with catalysts ahead, says Canaccord
Apr 03
6:09am ET
Atai Life Sciences price target lowered to $15 from $20 at H.C. Wainwright
Mar 28
11:32am ET
Rising High: Exclusive talk with financial services firm Safe Harbor Financial
Mar 28
7:11am ET
Atai Life Sciences sees cash runway into 2026
Mar 28
7:10am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 28
7:10am ET
Atai Life Sciences reports Q4 EPS (12c), consensus (16c)
Mar 27
11:55am ET
Buy Rating Affirmed for ATAI Life Sciences on Promising TRD Treatment Trial Outcomes and Strong Valuation Prospects
Mar 27
7:12am ET
Atai Life announces initial results from Psytech’s Phase 2a study of BPL-003
Mar 21
10:52am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Mar 14
11:15am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Mar 11
7:53am ET
IntelGenx enters amended, restated loan agreement with atai Life Sciences
Mar 07
1:09pm ET
Rising High: Exclusive talk with multi-state operator C3 Industries
Mar 07
10:46am ET
Rising High: Exclusive talk with vape tech developer Ispire Technology
Mar 04
8:19am ET
Atai Life Sciences announces first patint dosed in Phase 1b trial of VLS-01
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 07
5:14am ET
ATAI Life Sciences Signals Executive Shakeup and Strategy Shift
Feb 07
5:14am ET
ATAI Life Sciences Announces New CFO Appointment and Transition
Feb 06
5:01pm ET
Atai Life Sciences names Anne Johnson CFO
No recent press releases are available for ATAI
ATAI Financials
Key terms
Ad Feedback
ATAI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ATAI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range